PATENT CLAIM ANALYSIS

Application Number: 15877134
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "019300"]

Abstract:
This invention relates, e.g., to an inhibitory peptide or CPP inhibitor which specifically binds to p53 having an aberrant conformation (e.g., is aggregated or misfolded) and inhibits p53 amyloidogenic aggregation or restores proper folding of the misfolded protein. Methods of using the inhibitory peptide or CPP inhibitor (e.g. to treat subjects having tumors that comprise aggregated p53) are described.

Claim (Index 29):
The method of  claim 28  wherein the composition lowers the amount of p53 aggregates, or restores the folding of a misfolded p53.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.53333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14889604', '14350390', '15796811', '15015208', '14741951']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.776693611224713
- 35 USC 102 Novelty (BERT): 0.5645513814397155
- Combined Prediction Score: 0.7554793882462133
- Mean Citation Score: 294.199264
- Max Citation Score: 486.2259
- Similarity Product: 311.8360691641689

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test